STOCKHOLM, Sweden--(BUSINESS WIRE)--RaySearch Laboratories AB (STO:RAYB) announces that a long-term license and development agreement has been reached with Royal Philips Electronics covering a suite of new products within adaptive radiation therapy. The agreement covers three products, the first of which will be launched during the second half of 2007. Adaptive radiation therapy, considered to be the next technology shift within radiation therapy, increases geometric precision by taking into account changes in the patient’s anatomy during the actual treatment. The higher precision makes it possible to deliver higher doses to the tumor and at the same time reduce side-effects.
